Geron
GERN
#7153
Rank
โ‚น59.87 B
Marketcap
โ‚น92.93
Share price
-0.03%
Change (1 day)
-9.61%
Change (1 year)

Earnings for Geron (GERN)

Earnings in 2026 (TTM): -โ‚น3.39 Billion

According to Geron's latest financial reports the company's current earnings are โ‚น0.20 Billion. In 2025 the company made an earning of -โ‚น4.78 Billion, an increase over its 2024 earnings that were of -โ‚น14.66 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Geron from 1996 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -โ‚น3.39 Billion-29.17%
2025 -โ‚น4.78 Billion-67.42%
2024 -โ‚น14.66 Billion-11.23%
2023 -โ‚น16.52 Billion30.22%
2022 -โ‚น12.69 Billion20.15%
2021 -โ‚น10.56 Billion50.08%
2020 -โ‚น7.04 Billion4.46%
2019 -โ‚น6.74 Billion130.68%
2018 -โ‚น2.92 Billion8.84%
2017 -โ‚น2.69 Billion-3.08%
2016 -โ‚น2.77 Billion-22080.6%
2015 โ‚น12.58 M-100.38%
2014 -โ‚น3.35 Billion-7.14%
2013 -โ‚น3.6 Billion
2011 -โ‚น8.52 Billion19.04%
2010 -โ‚น7.16 Billion8.45%
2009 -โ‚น6.6 Billion-2.51%
2008 -โ‚น6.77 Billion14.65%
2007 -โ‚น5.91 Billion32.68%
2006 -โ‚น4.45 Billion25.59%
2005 -โ‚น3.55 Billion4.36%
2004 -โ‚น3.4 Billion19.73%
2003 -โ‚น2.84 Billion-15.46%
2002 -โ‚น3.36 Billion1.94%
2001 -โ‚น3.29 Billion33.59%
2000 -โ‚น2.47 Billion27.53%
1999 -โ‚น1.94 Billion63.13%
1998 -โ‚น1.19 Billion15.6%
1997 -โ‚น1.03 Billion-10.66%
1996 -โ‚น1.15 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Gilead Sciences
GILD
-โ‚น183.61 Billion 5,130.35%๐Ÿ‡บ๐Ÿ‡ธ USA
Incyte
INCY
โ‚น74.77 B-2,230.15%๐Ÿ‡บ๐Ÿ‡ธ USA
CTI BioPharma
CTIC
-โ‚น6.51 Billion 85.24%๐Ÿ‡บ๐Ÿ‡ธ USA
Bio-Techne
TECH
โ‚น23.50 B-769.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
-โ‚น1.56 Billion-55.80%๐Ÿ‡บ๐Ÿ‡ธ USA